Harnessing microRNA-enriched extracellular vesicles for liquid biopsy

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Extracellular microRNAs (miRNAs) in body fluids are potential cancer biomarkers.
• miRNAs are protected from degradation within extracellular vesicles (EVs) or protein complexes.
• Assaying EV-miRNAs may enhance diagnostic performance over total cell-free miRNAs.

Purpose of the Study:

• To review strategies for identifying and isolating cancer cell-derived, miRNA-rich EVs.
• To address challenges hindering the clinical application of EV-miRNAs in liquid biopsy.
• To discuss candidate EV membrane proteins and methods for EV subpopulation identification.

Main Methods:

• Literature review of current research on extracellular miRNAs and EVs.
• Discussion of EV membrane proteins (e.g., CD147) for cancer-derived EV identification.
• Exploration of methods for isolating specific EV subpopulations rich in miRNAs.

Main Results:

• Cancer cell-derived EVs may be a minor fraction in body fluids, complicating detection.
• EV subpopulations vary in miRNA cargo, with many containing low miRNA copy numbers.
• Candidate proteins like CD147 show potential for identifying cancer-derived EVs.

Conclusions:

• Isolating cancer cell-derived, miRNA-rich EVs is crucial for improving liquid biopsy sensitivity.
• Targeting specific EV subpopulations and utilizing marker proteins are key strategies.
• Further research is needed to overcome current challenges and advance EV-miRNA diagnostics.